We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.9B
AUM Growth
+$317M
Cap. Flow
-$92.4M
Cap. Flow %
-1.56%
Top 10 Hldgs %
47.94%
Holding
165
New
49
Increased
48
Reduced
28
Closed
27

Top Sells

Rank Stock Value
1
CPB icon
Campbell Soup
CPB
+$59.8M
2
LULU icon
lululemon athletica
LULU
+$56.9M
3
AMZN icon
Amazon
AMZN
+$46.6M
4
TH icon
Target Hospitality
TH
+$46.3M
5
ALKS icon
Alkermes
ALKS
+$43.6M

Sector Composition

Rank Sector Weight
1 Healthcare 44.61%
2 Consumer Discretionary 7.96%
3 Consumer Staples 6.71%
4 Communication Services 3.41%
5 Technology 2.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BUD icon
26
AB InBev
BUD
$170B
$52.8M 0.89%
936,000
+480,000
+105% +$30.1M
PCRX icon
27
Pacira BioSciences
PCRX
$1.04B
$52.4M 0.89%
+936,000
New +$53.9M
BHVN
28
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$52.2M 0.88%
376,000
-124,000
-25% -$15.5M
WMT icon
29
Walmart Inc
WMT
$885B
$51.6M 0.87%
1,111,029
+456,246
+70% +$22M
BLUE
30
DELISTED
bluebird bio
BLUE
$47.2M 0.8%
190,838
+49,099
+35% +$14M
BAX icon
31
Baxter International
BAX
$13.5B
$46.6M 0.79%
+580,000
New +$45.8M
UBER icon
32
Uber
UBER
$143B
$43.5M 0.74%
972,000
-120,000
-11% -$5.24M
CRSP icon
33
CRISPR Therapeutics
CRSP
$4.73B
$42.5M 0.72%
380,000
+222,000
+141% +$27.9M
OCDX
34
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$42.5M 0.72%
2,300,000
+628,000
+38% +$12.6M
ROST icon
35
Ross Stores
ROST
$80.5B
$42.3M 0.72%
389,027
+97,115
+33% +$11.6M
JAZZ icon
36
Jazz Pharmaceuticals
JAZZ
$15.9B
$42.2M 0.71%
+324,000
New +$49M
ILMN icon
37
Illumina
ILMN
$31B
$42.2M 0.71%
106,912
+61,680
+136% +$28.4M
CENTA icon
38
Central Garden & Pet Co Class A
CENTA
$2.37B
$41.1M 0.7%
1,195,000
+250,000
+26% +$8.64M
ORLY icon
39
O'Reilly Automotive
ORLY
$72.9B
$40.9M 0.69%
1,002,945
+83,670
+9% +$3.35M
LOW icon
40
Lowe's Companies
LOW
$117B
$39.8M 0.67%
+196,422
New +$39.1M
PARA
41
DELISTED
Paramount Global Class B
PARA
$39.5M 0.67%
1,000,000
+104,000
+12% +$4.24M
UNH icon
42
UnitedHealth
UNH
$376B
$39.1M 0.66%
100,000
AMZN icon
43
Amazon
AMZN
$2.92T
$37.8M 0.64%
230,000
-270,000
-54% -$46.6M
TTWO icon
44
Take-Two Interactive
TTWO
$45.4B
$36.4M 0.62%
236,000
+100,000
+74% +$16.2M
SPPI
45
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$35.8M 0.61%
16,400,000
+5,352,000
+48% +$14.6M
META icon
46
Meta Platforms (Facebook)
META
$1.42T
$35.3M 0.6%
104,000
+20,000
+24% +$7.2M
HOLX
47
DELISTED
Hologic
HOLX
$35.3M 0.6%
478,000
-154,000
-24% -$11.5M
POST icon
48
Post Holdings
POST
$4.14B
$34.4M 0.58%
+476,736
New +$33.8M
TMO icon
49
Thermo Fisher Scientific
TMO
$213B
$34.3M 0.58%
60,000
-15,000
-20% -$8.23M
BBY icon
50
Best Buy
BBY
$18.2B
$34.3M 0.58%
+324,182
New +$36.4M

Similar funds

Armistice Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Armistice Capital held 165 positions worth $5.9B, up 5.7% from $5.59B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Armistice Capital's Q3 2021 filing shows 49 new, 48 increased, 28 reduced and 27 closed positions. Its largest new stake was Five Below: 381,266 shares worth $67.4M. The largest sale was Campbell Soup, an estimated $59.8M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 44% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Armistice Capital's largest Q3 2021 buy was Five Below: 381,266 shares worth $67.4M.
  • Armistice Capital added most to Incyte in Q3 2021, an estimated $107M increase.
  • Armistice Capital's biggest Q3 2021 reduction was Amazon, cutting an estimated $46.6M.
  • Armistice Capital fully exited Campbell Soup in Q3 2021, selling an estimated $59.8M.
  • Armistice Capital's ten largest holdings make up 48% of its $5.9B portfolio in Q3 2021.
  • Armistice Capital opened 49 new positions and closed 27 in Q3 2021.
  • Armistice Capital's portfolio value rose 5.7% quarter-over-quarter to $5.9B.

Based on Armistice Capital's 13F filing for Q3 2021, filed 15 Nov 2021.